Literature DB >> 21943708

Mechanisms of mannose-binding lectin-associated serine proteases-1/3 activation of the alternative pathway of complement.

Nirmal K Banda1, Minoru Takahashi, Kazue Takahashi, Gregory L Stahl, Stephanie Hyatt, Magdalena Glogowska, Timothy A Wiles, Yuichi Endo, Teizo Fujita, V Michael Holers, William P Arend.   

Abstract

Mannose-binding lectin-associated serine proteases-1/3 (MASP-1/3) are essential in activating the alternative pathway (AP) of complement through cleaving pro-factor D (pro-Df) into mature Df. MASP are believed to require binding to mannose binding lectins (MBL) or ficolins (FCN) to carry out their biological activities. Murine sera have been reported to contain MBL-A, MBL-C, and FCN-A, but not FCN-B that exists endogenously in monocytes and is thought not to bind MASP-1. We examined some possible mechanisms whereby MASP-1/3 might activate the AP. Collagen antibody-induced arthritis, a murine model of inflammatory arthritis dependent on the AP, was unchanged in mice lacking MBL-A, MBL-C, and FCN-A (MBL(-/-)/FCN A(-/-) mice) in comparison to wild-type mice. The in vitro induction of the AP by adherent mAb to collagen II was intact using sera from MBL(-/-)/FCN A(-/-) mice. Furthermore, sera from MBL(-/-)/FCN A(-/-) mice lacked pro-Df and possessed only mature Df. Gel filtration of sera from MBL(-/-)/FCN A(-/-) mice showed the presence of MASP-1 protein in fractions containing proteins smaller than the migration of MBL-A and MBL-C in sera from C4(-/-) mice, suggesting possible binding of MASP-1 to an unknown protein. Lastly, we show that FCN-B was present in the sera of MBL(-/-)/FCN A(-/-) mice and that it was bound to MASP-1. We conclude that MASP-1 does not require binding to MBL-A, MBL-C, or FCN-A to activate the AP. MASP-1 may cleave pro-Df into mature Df through binding to FCN-B or to an unknown protein, or may function as an unbound soluble protein.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21943708      PMCID: PMC3226714          DOI: 10.1016/j.molimm.2011.08.021

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  47 in total

Review 1.  The biological functions of MBL-associated serine proteases (MASPs).

Authors:  Krishnan Hajela; Mayumi Kojima; Geza Ambrus; K H Nicky Wong; Beryl E Moffatt; Janez Ferluga; Sumati Hajela; Peter Gál; Robert B Sim
Journal:  Immunobiology       Date:  2002-09       Impact factor: 3.144

2.  Mannose-binding lectin binds IgM to activate the lectin complement pathway in vitro and in vivo.

Authors:  Meghan E McMullen; Melanie L Hart; Mary C Walsh; Jon Buras; Kazue Takahashi; Gregory L Stahl
Journal:  Immunobiology       Date:  2006-07-28       Impact factor: 3.144

3.  Identification and characterization of a novel human collectin CL-K1.

Authors:  Hiroyuki Keshi; Takashi Sakamoto; Takao Kawai; Katsuki Ohtani; Tsuyoshi Katoh; Seong-Jae Jang; Wataru Motomura; Takayuki Yoshizaki; Mitsuko Fukuda; Satoshi Koyama; Jun Fukuzawa; Atsushi Fukuoh; Itsuro Yoshida; Yasuhiko Suzuki; Nobutaka Wakamiya
Journal:  Microbiol Immunol       Date:  2006       Impact factor: 1.955

4.  Interaction properties of human mannan-binding lectin (MBL)-associated serine proteases-1 and -2, MBL-associated protein 19, and MBL.

Authors:  N M Thielens; S Cseh; S Thiel; T Vorup-Jensen; V Rossi; J C Jensenius; G J Arlaud
Journal:  J Immunol       Date:  2001-04-15       Impact factor: 5.422

5.  Substrate specificities of recombinant mannan-binding lectin-associated serine proteases-1 and -2.

Authors:  V Rossi; S Cseh; I Bally; N M Thielens; J C Jensenius; G J Arlaud
Journal:  J Biol Chem       Date:  2001-08-29       Impact factor: 5.157

6.  Characterization of the interaction between L-ficolin/p35 and mannan-binding lectin-associated serine proteases-1 and -2.

Authors:  Sandor Cseh; Loanys Vera; Misao Matsushita; Teizo Fujita; Gérard J Arlaud; Nicole M Thielens
Journal:  J Immunol       Date:  2002-11-15       Impact factor: 5.422

7.  Human IgA activates the complement system via the mannan-binding lectin pathway.

Authors:  A Roos; L H Bouwman; D J van Gijlswijk-Janssen; M C Faber-Krol; G L Stahl; M R Daha
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

8.  Interaction of mannose-binding protein with associated serine proteases: effects of naturally occurring mutations.

Authors:  R Wallis; R B Dodd
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

9.  Proteolytic activities of two types of mannose-binding lectin-associated serine protease.

Authors:  M Matsushita; S Thiel; J C Jensenius; I Terai; T Fujita
Journal:  J Immunol       Date:  2000-09-01       Impact factor: 5.422

10.  Natural substrates and inhibitors of mannan-binding lectin-associated serine protease-1 and -2: a study on recombinant catalytic fragments.

Authors:  Géza Ambrus; Péter Gál; Mayumi Kojima; Katalin Szilágyi; Júlia Balczer; József Antal; László Gráf; Andreas Laich; Beryl E Moffatt; Wilhelm Schwaeble; Robert B Sim; Péter Závodszky
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

View more
  17 in total

1.  Roles of adipocytes and fibroblasts in activation of the alternative pathway of complement in inflammatory arthritis in mice.

Authors:  William P Arend; Gaurav Mehta; Alexandra H Antonioli; Minoru Takahashi; Kazue Takahashi; Gregory L Stahl; V Michael Holers; Nirmal K Banda
Journal:  J Immunol       Date:  2013-05-06       Impact factor: 5.422

Review 2.  Targeting mechanisms at sites of complement activation for imaging and therapy.

Authors:  V Michael Holers
Journal:  Immunobiology       Date:  2015-04-30       Impact factor: 3.144

Review 3.  Complement regulation and kidney diseases: recent knowledge of the double-edged roles of complement activation in nephrology.

Authors:  Masashi Mizuno; Yasuhiro Suzuki; Yasuhiko Ito
Journal:  Clin Exp Nephrol       Date:  2017-03-24       Impact factor: 2.801

4.  Interaction of extremophilic archaeal viruses with human and mouse complement system and viral biodistribution in mice.

Authors:  Linping Wu; Kristine Buch Uldahl; Fangfang Chen; Halli Benasutti; Deborah Logvinski; Vivian Vu; Nirmal K Banda; Xu Peng; Dmitri Simberg; Seyed Moein Moghimi
Journal:  Mol Immunol       Date:  2017-08-30       Impact factor: 4.407

Review 5.  The properdin pathway: an "alternative activation pathway" or a "critical amplification loop" for C3 and C5 activation?

Authors:  Richard A Harrison
Journal:  Semin Immunopathol       Date:  2017-11-22       Impact factor: 9.623

Review 6.  Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: a critical review.

Authors:  Emanual Maverakis; Kyoungmi Kim; Michiko Shimoda; M Eric Gershwin; Forum Patel; Reason Wilken; Siba Raychaudhuri; L Renee Ruhaak; Carlito B Lebrilla
Journal:  J Autoimmun       Date:  2015-01-09       Impact factor: 7.094

7.  Endogenous and natural complement inhibitor attenuates myocardial injury and arterial thrombogenesis.

Authors:  Vasile I Pavlov; Mikkel-Ole Skjoedt; Ying Siow Tan; Anne Rosbjerg; Peter Garred; Gregory L Stahl
Journal:  Circulation       Date:  2012-10-02       Impact factor: 29.690

8.  Oxidative stress sensitizes retinal pigmented epithelial (RPE) cells to complement-mediated injury in a natural antibody-, lectin pathway-, and phospholipid epitope-dependent manner.

Authors:  Kusumam Joseph; Liudmila Kulik; Beth Coughlin; Kannan Kunchithapautham; Mausumi Bandyopadhyay; Steffen Thiel; Nicole M Thielens; V Michael Holers; Bärbel Rohrer
Journal:  J Biol Chem       Date:  2013-03-14       Impact factor: 5.157

9.  Fibrinogen-specific antibody induces abdominal aortic aneurysm in mice through complement lectin pathway activation.

Authors:  Hui-fang Zhou; Huimin Yan; Paula Bertram; Ying Hu; Luke E Springer; Robert W Thompson; John A Curci; Dennis E Hourcade; Christine T N Pham
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-28       Impact factor: 11.205

Review 10.  Complement in disease: a defence system turning offensive.

Authors:  Daniel Ricklin; Edimara S Reis; John D Lambris
Journal:  Nat Rev Nephrol       Date:  2016-05-23       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.